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Olive leaf extract (OLE) is used in traditional medicine as a food supplement and
as an over-the-counter drug for a variety of its effects, including anti-inflammatory
and anti-atherosclerotic ones. Mechanisms through which OLE could modulate these
pathways in human vasculature remain largely unknown. Serum amyloid A (SAA) plays a
causal role in atherosclerosis and cardiovascular diseases and induces pro-inflammatory
and pro-adhesive responses in human coronary artery endothelial cells (HCAEC).
Within this study we explored whether OLE can attenuate SAA-driven responses in
HCAEC. HCAEC were treated with SAA (1,000 nM) and/or OLE (0.5 and 1 mg/ml). The
expression of adhesion molecules VCAM-1 and E-selectin, matrix metalloproteinases
(MMP2 and MMP9) and microRNA 146a, let-7e, and let-7g (involved in the regulation
of inflammation) was determined by qPCR. The amount of secreted IL-6, IL-8, MIF,
and GRO-α in cell culture supernatants was quantified by ELISA. Phosphorylation of
NF-κB was assessed by Western blot and DNA damage was measured using the
COMET assay. OLE decreased significantly released protein levels of IL-6 and IL-8,
as well as mRNA expression of E-selectin in SAA-stimulated HCAEC and reduced
MMP2 levels in unstimulated cells. Phosphorylation of NF-κB (p65) was upregulated
in the presence of SAA, with OLE significantly attenuating this SAA-induced effect.
OLE stabilized SAA-induced upregulation of microRNA-146a and let-7e in HCAEC,
suggesting that OLE could fine-tune the SAA-driven activity of NF-κB by changing
the microRNA networks in HCAEC. SAA induced DNA damage and worsened the
oxidative DNA damage in HCAEC, whereas OLE protected HCAEC from SAA- and
H2O2-driven DNA damage. OLE significantly attenuated certain pro-inflammatory and
pro-adhesive responses and decreased DNA damage in HCAEC upon stimulation with
SAA. The reversal of SAA-driven endothelial activation by OLE might contribute to its
anti-inflammatory and anti-atherogenic effects in HCAEC.
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INTRODUCTION
Cardiovascular diseases, including coronary artery disease, are
the leading cause of death globally, with atherosclerosis being the
most common underlying reason for cardiovascular morbidity
and mortality. In addition, systemic inflammation (present in
a number of chronic diseases, including metabolic syndrome
and rheumatoid arthritis) drives accelerated atherosclerosis (1)
and patients with these diseases are at risk for developing
atherosclerosis and its complications. Serum amyloid A (SAA), a
major acute phase protein, is increased in chronic inflammatory
diseases and coronary artery disease (2, 3). SAA was shown to be
an early causal agent for atherosclerosis in animal models (4, 5).
Serum levels of SAA have been reported to correlate with severity
of atherosclerosis (6, 7) and have been utilized as a predictor
of mortality following acute myocardial infarction (8, 9). In
addition, SAA was shown to enhance monocyte and lymphocyte
recruitment, directly stimulating foam cell formation, associating
with HDL/LDL particles and compromising reverse cholesterol
transport, among other processes (7). Furthermore, SAA was
reported to induce matrix metalloproteinases (MMP), as well
as increase biglycan synthesis and influence retention of
lipoproteins by vascular proteoglycans (10). Early on, Ridker
reported that even chronic low grade inflammation may
lead to atherosclerosis and the development of cardiovascular
diseases (11), emphasizing the importance of measuring systemic
inflammatory markers, such as SAA.
Atherosclerotic lesions typically develop in coronary arteries
and the activation of endothelium represents one of the
crucial early steps in the development of atherosclerotic
lesions in the coronary arterial system. Human coronary artery
endothelial cells (HCAEC) therefore represent a suitable in
vitro model to study the mechanisms of endothelial activation
and atherosclerosis. HCAEC strongly respond to stimulation
with SAA, activating a number of pro-inflammatory, pro-
adhesive and pro-coagulant responses, as measured by increased
expression of interleukin 6 (IL-6), interleukin 8 (IL-8), vascular
cell adhesion molecule (VCAM1) and tissue factor (12).
Elevated amounts of systemic SAA in patients with coronary
artery disease may represent a potential pathophysiological link
between inflammation, lipoprotein metabolism, oxidative stress
and the development of atherosclerosis (2). DNA damage is
emerging as a crucial player in accelerating the development
and progression of atherosclerosis. In addition to microRNAs,
which are important regulators of cellular processes leading to
atherosclerosis (13–15), DNA damage has been reported to be a
biomarker of atherosclerosis in monocytes (16). There is a lack of
information concerning whether DNA damage and alterations in
microRNA networks accompany or contribute to the SAA-driven
endothelial activation.
Olive oil represents the basis of atheroprotective effects of
the Mediterranean diet, and olive leaf extract (OLE) contains
a much higher concentration of active polyphenol compounds
compared with extra virgin olive oil (17). OLE from the olive
tree (Olea europaea L.) is used as a food supplement or as
an over-the-counter drug for a variety of benefits including
its anti-arrhythmic, anti-atherosclerotic (18), anti-hypertensive,
antioxidant, anti-tumor, anti-proliferative, anti-inflammatory
(19, 20), and anti-fibrotic (20, 21) effects. The 80% alcoholic
extract of olive leaves has also been included in the European
Pharmacopeia (Ph. Eur.) based on a subset of its protective
properties (20). The polyphenols of the olive tree activated major
anti-oxidant pathways, including transcription factor Nrf2, as
well as AMPK, IGF/Akt, and mTOR, thereby acting similarly to
caloric restriction mimickers (20).
Dry OLE is rich in water-soluble phenolic compounds,
specifically secoiridoid oleuropein (17%), whereas the remaining
compounds [apigenine-7-O-glucoside, luteolin-7-O-glucoside,
quercetin, and caffeic acid] are present in substantially smaller
amounts [<0.1%] (22). Secoiridoid oleuropein consists of a
polyphenolic molecule known as hydroxytyrosol, bound to
elenolic acid and a glucose molecule. OLE and its compounds
can repress the expression of a number of pro-inflammatory
genes. Specifically, oleuropein decreased the expression of IL-
6 and IL-1β in colon during DSS-induced colitis (23) and
in LPS-stimulated macrophages (Raw264.7) (24). Peripheral
blood mononuclear cells (PBMC) from healthy individuals, who
consumed OLE on a single occasion, expressed less IL-8 when
stimulated ex vivowith LPS (25), and serum IL-8 levels decreased
in hypertensive individuals who consumed OLE for 6 weeks
(26). IL-8 was also one of the most downregulated genes in
PBMC from healthy subjects who consumed OLE for 8 weeks.
The major contributors to these effects were downregulation of
the arachidonic acid and NF-κB pathways by OLE (27). The
inflammatory molecules MCP-1, VCAM-1, and TNF-α were
down-regulated in thoracic aorta of rabbits on a high lipid diet
supplemented with OLE, as compared to a high lipid diet alone
(18). Oleuropein and hydroxytyrosol, the constituents of OLE,
inhibited the expression of both VCAM-1 and ICAM-1 in
human umbilical vein endothelial cells, further accompanied by a
decreased activation of NF-κB and AP-1 and reduced monocyte
adhesion (28). These studies suggest that OLE could affect pro-
inflammatory and pro-adhesive cellular responses during the
atherosclerotic process in the arterial wall.
In our present work, we show that OLE significantly
attenuated the SAA-driven pro-inflammatory and pro-adhesive
responses of HCAEC and modulated SAA-induced miR-146a
and let-7e. OLE decreased SAA-induced phosphorylation
of NF-κB and protected endothelial cells from SAA-
induced DNA damage. This suggests that OLE might
exhibit multiple athero-protective effects in coronary
arterial vasculature.
MATERIALS AND METHODS
Materials
Lyophilized human recombinant SAA (Peprotech EC Ltd.,
London, UK) was reconstituted according to manufacturer’s
instructions to stock concentration and stored until usage at
−20 or −80◦C. The final concentration of SAA in experiments
was 1,000 nM. Dry OLE EFLA R©943 (Frutarom Switzerland
Ltd., Wadenswil, Switzerland) was originally manufactured by
applying an ethanol extraction procedure (80% m/m) from the
dried leaves of olive tree, standardized to 16–24% of oleuropein.
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Dry OLE powder was diluted in phosphate buffered saline (PBS)
to a final concentration of 0.1 g/ml, unless otherwise indicated.
Cell Culture
HCAEC from four different donors were purchased from
Lonza (Walkesville, Maryland, USA). The cells were plated
onto 25 cm2 flasks and 6 or 24 well-plates (TPP, Trasadigen,
Switzerland) and cultured at 37◦C in a humidified atmosphere
at 5% CO2. HCAEC were grown in EGM-2M medium
(CambrexBioScience, Walkesville, Maryland, USA) containing
5% fetal bovine serum. For experiments, subconfluent cell
cultures were used between passages 4 and 6 in serum-free
medium, with pretreatment of OLE for 45min, followed by
addition of SAA for 24 h, unless otherwise indicated. Prior
to experiments, cells were incubated in serum-free medium
for 2 h.
RNA Isolation and Reverse Transcription
Polymerase Chain Reaction Analysis
Prior to reverse transcription polymerase chain reaction
(RT-PCR), total RNA from endothelial cell cultures was
isolated using Total RNA Isolation System RNeasyPlus Micro
(Qiagen, Germany), following manufacturer’s instructions.
The purity and amount of RNA were determined by
measuring the OD at a ratio of 260 to 280 nm. One
microgram of total RNA was transcribed into cDNA by
Reverse Transcription System (Promega, Madison, WI,
USA). For microRNA measurements, 5 ng of total RNA
was reverse-transcribed using the TaqMan R©MicroRNA
Reverse Transcription Kit and miRNA-specific RT primers
(Applied Biosystems).
Real Time PCR
The expression of mRNA was measured with real time PCR
ABI Step One (Applied Biosystems, Foster City, CA, USA)
using Kapa Sybr master mix (Sigma-Aldrich, Germany), forward
and reverse primers (200 nM each) and 10 ng cDNA per well.
Primer sequences and conditions for RT-PCR are indicated for
each primer set in Supplementary Table 1. Dissociation curves
showed one peak in each PCR reaction. All experiments were
performed in triplicates. GAPDH was used as an endogenous
normalization control. The gene expression results were
calculated with the 2Ct11 method. The expression of microRNAs
was determined with real-time PCR (7900HT Fast real-time
PCR system) using TaqMan R©probes and TaqMan Universal PCR
Master Mix (all Applied Biosystems, Life Technologies Foster
City, CA, USA). RNU48 was used as an endogenous control.
Differences in microRNA expression were calculated with the
2Ct11 method.
Western Blot
Whole cell lysates were prepared from HCAEC using RIPA
buffer containing Halt protease inhibitors (Pierce, Rockford,
IL, USA) and phosphatase inhibitors (Cayman Chemical, Ann
Arbor, MI, USA). The concentration of proteins was determined
with the Bradford assay and equal amounts of proteins were
loaded per gel pocket. α-tubulin was used as a loading control.
Whole cell lysates, mixed with loading buffer, were separated
on 10% SDS polyacrylamide gels and electroblotted onto
nitrocellulose membranes (Whatman). Membranes were blocked
for 1 h in 5 % (w/v) non-fat milk in TBS-T. After blocking,
the membranes were probed with rabbit anti-phospho NF-κB
p65 and rabbit anti-NF-κB p65 (S536 and E498, respectively,
both at dilutions of 1:1000 Cell Signaling Technology, Danvers,
MA, USA). As secondary antibodies, horseradish peroxidase-
conjugated goat anti-rabbit (Cell Signaling Technology, Danvers,
MA, USA) were used. Signals were detected using Femto
Luminol (ThermoFisher Scientific, Hempstead, UK) with G:Box
(Syngene, Cambridge,UK). Densitometry analysis of protein
bands was carried out using the Fusion FX software (Vilber
Lourmat). For quantification of Western blots, the levels
of phosphorylated NF-κB were normalized to the levels of
total NF-κB.
Protein Detection by ELISA
Supernatants from untreated and treated HCAEC were
spun down (300 g, 5min) and cell-free supernatants frozen
at −80◦C until usage. The assays were performed using
commercial ELISA kits and were done in duplicates, according
to the manufacturers‘ instructions. IL-6 and IL-8 ELISA
kits were purchased from Invitrogen (Frederick, MD, USA),
while GROa and MIF quantikine ELISA were from R&D
Systems (Minneapolis, USA). Absorbance was measured
at 450 nm with the microplate absorbance reader (Tecan,
Groening, Austria). The concentrations of analytes were
calculated from standard curves and multiplied by the
dilution factor.
Comet Assay
HCAEC were grown in 6 well-plates. After treatment with SAA
± OLE, cells were detached using Acutasse (Sigma Aldrich)
and spun down (5min, 300 g). COMET was performed as
previously described (29). Briefly, cells were resuspended in
0.067% low melting agarose (Sigma Aldrich) at 370C and were
layered onto slides using a coverslip. Cells from each 6 well
were layered onto 4 slides and after cooling at 40C for 10min,
coverslips were removed. Two slides were treated with 3%
H2O2 at 37◦C and rinsed with PBS. The remaining two slides
were immediately covered with an additional layer of 0.05%
low melting agarose and were placed (after cooling) into fresh
alkaline lysis buffer overnight. The lysis buffer was prepared from
89ml of stock solution containing 2.5M NaCl, 100mM EDTA,
10mM Tris-base at pH 10, 10ml DMSO and 1ml Triton-X.
Slides were then immersed into cold, alkaline electrophoresis
buffer (300mMNaOH, 1mM EDTA freshly prepared from stock
10M NaOH and stock 200mM EDTA, pH 10) for 30min, after
which electrophoresis was run (30min, 25V, 300mA). This was
followed by 2 repeated rinses for 10min with neutralization
buffer (0.32M Tris base at pH 7.5) and water. Slides were
stained with Sybr Green I, and 100 cells per slide were scored
under the fluorescence microscope (Nikon eclipse TE 300 and
AxioImager Z1, Carl Zeiss, 400x magnification). The average of
the duplicate slides was calculated and three biological replicates
were performed per experimental condition (Scheme 1).
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SCHEME 1 | Scheme of COMET Analysis.
Statistical Analysis
Data was presented as mean ± standard deviation (SD),
unless otherwise indicated. The differences between the various
treated and control groups were analyzed with RM one way
ANOVA test with Tukey’s method for multiple comparisons.
All data was analyzed with the GraphPad Prism 7.0 software. A
difference of p < 0.05 was considered statistically significant.
DIANA-miRPath v3.0 software was used for assessment of
miRNA regulatory roles and the identification of controlled
pathways (30).
RESULTS
OLE Reduces the SAA-Driven Release of
Pro-Inflammatory Cytokines and
Chemokines From HCAEC
Treatment of HCAEC with OLE alone or in combination with
SAA did not decrease the viability of HCAEC when compared
to untreated cells (data not show). Inflammatory chemokines
and cytokines play an important role in recruiting inflammatory
cells and sustaining inflammation in chronic inflammatory
diseases. To mimic the inflammatory milieu in the vasculature
of patients with an activated systemic inflammatory response, we
stimulated HCAEC with SAA (1000 nM or 12 mg/l). While high
concentrations of SAA are commonly reached in the circulation
of patients with infections, inflammatory and autoimmune
diseases or trauma (31), chronically elevated low levels of SAA
can already cause atherosclerosis (11). Stimulation of HCAEC
with SAA significantly increased the release of IL-6, IL-8, and
MIF (Figures 1A,B). Treatment with OLE reduced this SAA-
induced release of IL-6 and IL-8 in a dose-dependent manner
(Figures 1A,B). While 1 mg/ml OLE significantly decreased the
release of IL-6 into supernatants of the SAA-stimulated HCAEC,
the release of IL-8 returned to baseline levels. Additionally,
similar effects of OLE were observed on the SAA-driven release
of GROα, although significant changes were not observed
(most probably due to large differences in the basal production
of GROα in HCAEC). SAA-driven release of MIF was not
affected (Figures 1C,D). Overall, this suggests that OLE can
modulate the expression of a subset of the SAA-induced pro-
inflammatory genes.
OLE Alters the mRNA Expression of
SAA-Induced E-Selectin in HCAEC
SAA significantly increased the expression of E-selectinmRNA in
HCAEC, whereas VCAM-1 mRNA was up-regulated on average
4-fold above baseline with a notable variation between the
donors (significance not reached) (Figures 2A,B). SAA-driven
upregulation of E-selectin mRNA returned to baseline in the
presence of OLE (Figure 2B). Moreover, OLE significantly down-
regulated the constitutive expression of both E-selectin and
VCAM-1mRNAs (Figures 2A,B). While SAA strongly enhanced
pro-inflammatory and pro-adhesive activities in HCAEC, it did
not alter significantly the expression of MMP2, MMP9 and
mRNAs (Figures 2C,D).
SAA-Induced NF-κB Phosphorylation Is
Reduced by OLE
The SAA-induced activation of gene expression coincided with
the increase in the phosphorylation of NF-κB p65 (Figure 3).
NF-κB is the central transcription factor in the expression of
pro-inflammatory genes including those coding for cytokines,
chemokines, and adhesion molecules (32). The SAA-increased
phosphorylation of NF-κB was decreased in the presence of
OLE (Figure 3). This shows that OLE could exert its anti-
inflammatory and anti-adhesive effect also through modulation
of NF-κB signaling.
OLE Protects HCAEC From SAA-Induced
and H2O2-Induced DNA Damage
Oxidative stress occurs when the formation of free radicals
increases or when the antioxidant capacity of a cell is decreased,
leading to DNA damage (33). COMET assay is a sensitive
method to measure DNA damage in cells (34), where the relative
amount of DNA in the COMET tail indicates the frequency
of DNA breaks. Our results demonstrated that under basal
conditions, on average 58% of HCAEC exhibited no COMET
tails (condition A), whereas only 8% of the SAA-treated HCAEC
were without COMET tails (Figure 4A). While 0.5 mg/ml OLE
largely mimicked the background control in category A, a smaller
percentage of cells, around 30%, exhibited no COMET tails
when treated with 1 mg/ml OLE (Figure 4A). Nevertheless, the
treatment with 0.5 mg/ml and 1 mg/ml OLE decreased DNA
damage in the SAA-treated HCAEC, with 38% and 40% of
HCAEC, respectively, exhibiting no DNA damage (no COMET
tails) (Figure 4A). This data shows that SAA induces DNA
damage in HCAEC, which can be largely prevented in the
presence of OLE. Furthermore, OLE decreased the susceptibility
of HCAEC to oxidative DNA damage, induced by treating the
cells with 3% H2O2 (Figure 4B). Less than 10% of untreated
cells and none of the SAA-stimulated cells were without COMET
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FIGURE 1 | OLE decreases SAA-driven release of pro-inflammatory cytokine IL-6 and chemokine IL-8 from HCAEC. The amount of IL-6 (A), IL-8 (B), MIF (C), and
GRO-α (D) in cell culture supernatants were measured by ELISA. The mean of 3 biological replicates is shown. HCAEC were treated with OLE (0.5 mg/ml, 1 mg/ml)
45min prior to SAA addition (1,000 nM, 24 h). Data was analyzed using RM one-way ANOVA test with Tukey’s multiple comparison test *p > 0.05 **p > 0.01.
tails (no DNA damage) upon exposure to H2O2, however the
percentage of HCAEC without COMET tails increased upon
treatment with OLE (Figure 4B). Furthermore, in presence of
H2O2, 28% and 42% cells showed severe DNA damage (category
E) in untreated and SAA-stimulated HCAEC, respectively. OLE
alone or in the presence of SAA attenuated this damage
(Figure 4B). Specifically, cells treated with OLE were evenly
distributed in all categories, and the percentage of cells in
category E was between 13 and 19% (Figure 4B). Collectively,
treatment with OLE protected HCAEC from oxidative DNA
damage, while the treatment of HCAEC with SAA worsened the
oxidative DNA damage.
Expression of the SAA-Induced miR-146a
and Let-7e Is Altered by OLE
MicroRNA networks play a key role in regulating pro-
inflammatory cell responses, as well as endothelial dysfunction.
However, the expression and function of microRNAs during
the SAA-driven endothelial activation remains largely unknown.
Scarce evidence exists showing that OLE affects the microRNA
profiles (35). To explore the alteration in microRNA networks
during the SAA-driven endothelial activation, we measured
the expression of miR-146a, let-7e, and let-7g with roles in
inflammation (36) (Figures 5A–C). Thesemeasurements showed
that SAA significantly increased the expression of miR-146a
and OLE ameliorated the SAA-driven induction of miR-146a
(Figure 5A) and let-7e (Figure 5B). The effects of SAA on the
expression of let-7g (Figure 5C), however, were not changed
from untreated HCAEC. Analysis of genes targeted with miR-
146a and mirR-let-7e [using ≫Diana≪ tool mirPath v3 (30)]
showed significant association with Toll like receptor signaling
(p = 0.005, n of genes targeted is 9), NF-kappa B signaling
(p = 0.009, number of genes targeted is 6, Figure 5D), ErbB
signaling pathway (p = 0.02, number of genes targeted is 7)
and Cell cycle (p = 0.03, number of genes targeted is 11)
KEGG pathways (37).
DISCUSSION
Our study provides novel data on the positive effects of
olive leaf extract on the human coronary artery endothelium
ex vivo. We show that OLE decreases levels of IL-6, IL-8
released protein and E-selectin mRNA in HCAEC in response
to the endogenous inflammatory SAA, likely by reducing
the SAA-driven phosphorylation of NF-κB p65. Furthermore,
OLE changes the SAA-driven miR-146a and let-7e expression
and decreases SAA-induced and H2O2-induced oxidative DNA
damage in HCAEC, indicating protection at multiple levels.
Using HCAEC in vitro cell culture model, we mimicked OLE’s
actions on the endothelial cell function. However, certain effects
could be elucidated further only by using in vivo models or
interventional human studies, e.g., the effects of OLE on the
cholesterol/triglyceride profiles (18, 26).
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FIGURE 2 | OLE decreases mRNA expression of adhesion molecules and MMP2 in HCAEC. The expression of VCAM-1 (A), E-selectin (B), MMP2 (C), and MMP9
(D) mRNA was determined by qPCR. Mean of 3 biological replicates is shown. HCAEC were treated with OLE (0.5 mg/ml, 1 mg/ml) 45min prior to SAA addition
(1,000 nM, 24 h). Data was analyzed using RM one way ANOVA test with Tukey’s multiple comparison test *p > 0.05 **p > 0.01; ****P < 0.0001.
FIGURE 3 | OLE attenuates SAA-induced phosphorylation of NF-κB. (A) Western blot shows phosphorylation of NF-κB in HCAEC pretreated with OLE for 1 h and
then treated with OLE ± SAA for 1 h (SAA 1,000 nM, OLE 1 mg/ml). Representative blot of n = 3 biological replicates. (B) Densitometry analysis of protein bands was
carried out using the Fusion FX software (Vilber Lourmat), n = 3 biological replicates. For quantification of Western blots, the levels of phosphorylated NF-κB were
normalized to the levels of total NF-κB. Equal amounts of protein were loaded per gel pocket. α-tubulin was used as a loading control.
Our results are in line with the human intervention study of
olive leaf supplementation, which identified NF-κB as a central
biological factor influenced by OLE (27). Similarly, a dietary
intervention study showed that contrary to butter and walnut
meals extra virgin olive oil did not elicit the phosphorylation of
NF-κB in PBMC from healthy individuals (38). Moreover, OLE
inhibited the phosphorylation of NF-κB and AP-1 in HUVEC
and Raw264 macrophages (24, 28). Polyphenol compounds,
such as oleuropein attenuated the phosphorylation of NF-κB in
mouse models of ileum ischemia/reperfusion (39) and spinal
cord injury (40). Overall, this suggests that active ingredients of
OLE might have a therapeutic potential in regulating the activity
of NF-κB.
We show that OLE decreases the SAA-induced release of
IL-6 and attenuates the SAA-driven IL-8 and pro-adhesive
E-selectin in HCAEC. Moreover, OLE decreased the basal
expression of both pro-adhesive molecules, VCAM-1 and E-
selectin, in HCAEC. All these molecules are critical effectors
in the atherosclerosis process (41–44). The attenuation of pro-
inflammatory responses causes a mediator-specific effect in
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FIGURE 4 | OLE attenuates SAA-induced and H2O2-induced DNA damage in HCAEC. COMET assay was performed without (A) and with oxidative treatment (3%
H2O2) (B). Average from 3 biological replicates of the COMET assay for each experimental condition was performed on duplicate slides, 100 cells were evaluated per
slide according to the following categories: A - no tail (no DNA damage), B - slight tail, C - strong signal in tail, but also in nucleus, D - majority of DNA in tail, E - no
DNA in round nucleus.
HCAEC, since MIF released protein levels were not affected
by OLE treatment. Our results are in line with the observed
decrease in serum IL-8 in different human interventional
studies upon OLE consumption (25–27) and the oleuropein-
driven amelioration of IL-6 production in the LPS-induced
Raw264 macrophages (24). Thus, OLE could have multiple
beneficial effects via reducing the pro-inflammatory responses in
different cell types participating in the atherosclerotic process.
Additionally, oleuropein efficiently reduced the expression of
VCAM-1 and E-selectin in HUVEC upon pro-inflammatory
stimulation with LPS, TNF-α and PMA (28), when compared
to other phytochemicals in the Mediterranean diet (e.g.,
elenolic acid and tyrosol in olive oil, resveratrol in wine).
Healthy volunteers and subjects with hypertriglyceridemia who
consumed extra virgin olive oil had significantly lower amounts
of sICAM-1 and sVCAM-1 in comparison with subjects
consuming refined olive oil, which contains no polyphenols
and tocopherols (45). Nevertheless, the effects of dietary olive
oil and extra virgin olive oil can partially be attributed to
the incorporation of oleic acid or other fatty acids in cell
membranes (46).
MMPs play an integral role in the atherosclerotic process
via remodeling the extracellular matrix and regulating the
migration of vascular smooth muscle cells. MMP2 and MMP9
decrease plaque stability and MMP2 appears to have a particular
deleterious/pro-atherogenic role (47). While SAA did not affect
the expression of MMP2 andMMP9mRNAs in our experiments,
OLE decreased the expression of MMP2 in HCAEC under
basal conditions. This suggests that OLE might have additional
(SAA-independent) beneficial effects on the MMP2-driven
atherosclerosis-associated remodeling of the vascular wall.
In addition to its anti-inflammatory and antiadhesive
activities, oleuropein acts as a potent free radical scavenger
that suppresses the production of reactive oxygen species in
different experimental systems including H2O2-induced cell
damage (19, 29). Here, we report a novel observation that SAA
(at 1,000 nM) induces DNA damage in HCAEC and increases
the sensitivity of HCAEC to oxidative DNA damage. These
SAA-driven effects were largely prevented in the presence of
OLE. Importantly, OLE also reduced the H2O2-driven oxidative
damage in the absence of SAA (Figure 4). The COMET assay
we have utilized in this report is increasingly used in regulatory
genotoxicity testing for the evaluation of DNA damage and
repair in various tissues (48). It is one of a few assays that
tests for both single stranded and double stranded DNA breaks,
as opposed to γ-2HAX, which detects only dsDNA breaks.
The COMET assay has become a well-established and well-
accepted molecular technique in human biomonitoring and
in clinical studies (49, 50). Moreover, COMET is one of the
measuring techniques of European Standards Committee on
Oxidative DNA Damage (ESCODD) (51). There are also several
advantages of using the COMET assay, namely, the assay can
be calibrated to give quantitative measures (52), it is a sensitive
test (53), which is cost-effective and is becoming easier to
perform, with the development of the high through-put Comet-
Chip (54). More recently, an EpiComet-Chip was developed
and validated for the assessment of DNA methylation status
(55). There appear to be opposing activities of SAA, namely
Frontiers in Cardiovascular Medicine | www.frontiersin.org 7 May 2019 | Volume 6 | Article 56
Burja et al. OLE Attenuates Inflammation in HCAEC
FIGURE 5 | OLE regulates SAA-induced miR-146a and let-7e. (A–C) represent fold changes of mRNA expression levels of miR-146a, let-7e and let-7g, respectively.
The mean is shown of 3 biological replicates. Data was analyzed using RM one way ANOVA test with Tukey’s multiple comparison test p-values are shown as follows
*p > 0.05, ***P < 0.001, ****P < 0.0001. (D) miR-146 and let-7e functional analysis showed significant influence on KEGG NF-κB signaling pathway (p = 0.009)
(37) with 6 predicted target genes (marked yellow).
substantial DNA damage induction vs. slightly increased or
stable viability (56, 57). This could be due to, on the one hand,
SAA inflammatory events causing DNA damage in HCAEC,
while on the other hand, viability might reflect the implication
of elevated SAA in multiple types of cancers (e.g., esophageal
squamous cell, ovarian, breast, lung, renal, and gastric) with
increasing levels correlating with severity of cancer stages
(58). The question then emerges whether SAA downregulates
expression of genes, such as p53, thus elevating cell survival
and cell cycle progression, which could be addressed in
the future.
At the microRNA level, we show that SAA increases the
expression of microRNA146a and let-7e in HCAEC, while OLE
significantly attenuates these SAA-induced effects. The activation
of NF-κB induces the expression of microRNA-146a, which acts
as a negative feedback regulator of NF-κB via targeting TRAF6
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and IRAK1/2. This controls the NF-κB transcriptional activity
in the presence of excessive pro-inflammatory stimulation (36).
Contrary to microRNA-146a, let-7e promotes the activation of
NF-κB by inhibiting the expression of IκB β in endothelial cells
(59). Thus, OLE could fine-tune SAA-driven activity of NF-κB by
altering cellular microRNA networks (60).
In regard to the DIANA-miRPath v3 data (30) combining
target prediction algorithms, withmanually curatedmiRNA:gene
interaction datasets to chart miR-146a and let-7e targets, the
following genes and their involvement in processes most likely
to be affected are, among others: TLR2 pathway (TLR2, TAB2,
AKT2, JUN, TRAF6, STAT1, IRF7, IRAK1, MAP3K7), NF-κB
pathway (TAB2, TRAF6, PTGS2, BCL2A1, IRAK1, MAP3K7),
ErbB pathway (GSK3B, EGFR, STAT5B, AKT2, JUN, CDKN1A,
ABL1) and cell cycle (GSK3B, CCNB1,CDC25B, SMAD4, RBL1,
CDC23, CDKN1A, PRKDC, MDM2, ABL1, CDC25A). Among
these genes, several are implicated in survival (BCL2A1, EGFR,
STAT5B), ubiquitin-mediated proteolysis (TAB, TRAF6, IRAK1,
MAP3K7, CDC23), anti-viral effects (IRF7), metabolism (AKT2,
GSK3B). Interestingly, the cell cycle genes included both
promoting (e.g., CDC23, CDC25A), as well as regulating (e.g.,
CDKN1A, CCNB1) genes of the cell cycle. In cells in general, it
would be interesting to determine whether SAA downregulates
PRKDC (elevating p53) and/or upregulates MDM2 (attenuating
p53). While in silico analysis tools and applications, such as
miRPath provide support to research, in vitro experimentation
will further be necessary to confirm specific gene involvement.
Possible mechanisms of SAA activity could include changes
in gene expression of pro-inflammatory cytokines, epigenetic
events (e.g., miRNA-related), as well as induced reactive oxygen,
nitrogen species, which may, in turn cause damage to cellular
components (e.g., DNA), leading to chronic acceleration of
chronic vascular disease, with OLE providing a counterbalance
to these processes. In line with this, our data suggests that
OLE exhibits multiple protective actions that could prevent
or attenuate pro-inflammatory activation, influence vascular
remodeling via modulation of MMP2 expression and may
prevent DNA damage in the coronary arterial endothelium. This
suggests that olive leaf extract, or its derivatives, might have
athero-protective actions also in vivo, which would need to be
further explored in the future.
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